You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Osteoporosis

Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women

  • Technology appraisal guidance
  • Reference number: TA160
  • Published:  27 October 2008
  • Last updated:  07 February 2018
  • Guidance
  • Tools and resources
  • Evidence
  • History

Osteoporosis - primary prevention: Decision Support Unit (DSU) report

  • Osteoporosis - primary prevention: DSU specification

  • Osteoporosis - primary prevention: DSU report

  • Osteoporosis - primary prevention: Servier response to Decision Support Unit report


This page was last updated: 07 December 2010

Back to top